Guardant Health, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportJul 30 →Insiders1 insider bought $78,456 in 1 open-market buy. 14 insiders sold $103.9M, 46 of 112 sales on a 10b5-1 plan.→HoldersBlackRock 5.7%Vanguard 4.3%FMR 4.1%→Financing →PeersClosest companies: BDSX, CSTL, FLGT→
From the filings
Figures
- Revenue
- $1.18Blast 12 months
- Net income
- −$453.5Mlast 12 months
- Operating cash flow
- −$187.7Mlast 12 months
- Cash and equivalents
- $1.05Bat the last balance sheet
- Total debt
- $1.50Bat the last balance sheet
- Shares outstanding
- 133.6M shareson issue